CRISPR

CRISPR1-hexb

ID
ZDB-CRISPR-200130-3
Name
CRISPR1-hexb
Previous Names
None
Target
Sequence
5' - AACAGTCCACCGCCGGAC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
re04 hexb
Expression
Gene expression in Wild Types + CRISPR1-hexb
No data available
Phenotype
Phenotype resulting from CRISPR1-hexb
Phenotype of all Fish created by or utilizing CRISPR1-hexb
Phenotype Fish Conditions Figures
head hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
spleen hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
brain hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
brain apoptotic, abnormal hexbre04/re04 standard conditions Fig. 4 with image from Kuil et al., 2019
brain oligosaccharide increased amount, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
pancreas oligosaccharide increased amount, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
microglial cell lysosome morphology, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
liver oligosaccharide increased amount, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
pancreas hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
gonad hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
gonad oligosaccharide increased amount, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
liver hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
locomotion decreased occurrence, abnormal hexbre04/re04 standard conditions Fig. 4 with image from Kuil et al., 2019
intestine oligosaccharide increased amount, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
spleen oligosaccharide increased amount, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
intestine hexosaminidase activity decreased process quality, abnormal hexbre04/re04 standard conditions Fig. 2 with image from Kuil et al., 2019
microglial cell lysosome increased size, abnormal WT + CRISPR1-hexb standard conditions Fig. 1 with image from Kuil et al., 2019
hexosaminidase activity decreased process quality, abnormal WT + CRISPR1-hexb standard conditions Fig. 1 with image from Kuil et al., 2019
Citations